Investor directory

Aisling Capital

Founded in 2000, Aisling Capital is a New York-based investment firm focusing on mid-market and growth-oriented investments in life sciences, healthcare, and technology companies across the United States and Western Europe. The company aims to support leading global healthcare companies commercializing new products driven by biotechnology advancements.
https://www.aislingcapital.com/
https://crunchbase.com/organization/***
https://linkedin.com/company/***
https://signal.nfx.com/firms/***
https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=3118641
https://www.privateequityinternational.com/database/#/profile?id=7769

Josh Bilenker

Partner

Steven Elms

Managing Partner

Dov Goldstein

Managing Partner

A.J Sacks

Analyst

Andrew Schiff

Managing Partner at Aisling Capital

Past deals in Kentucky

Xanodyne

Venture Round in 2009
Xanodyne Pharmaceuticals, Inc. operates as an integrated specialty pharmaceutical company that offers developing and commercializing products in women’s healthcare and pain management in the United States.The company was formerly known as Xanodyne Pharmacal, Inc. and changed the name to Xanodyne Pharmaceuticals, Inc. in February, 2004. Xanodyne Pharmaceuticals, Inc. was incorporated in 2000 and is based in Newport, Kentucky.

Xanodyne

Series A in 2007
Xanodyne Pharmaceuticals, Inc. operates as an integrated specialty pharmaceutical company that offers developing and commercializing products in women’s healthcare and pain management in the United States.The company was formerly known as Xanodyne Pharmacal, Inc. and changed the name to Xanodyne Pharmaceuticals, Inc. in February, 2004. Xanodyne Pharmaceuticals, Inc. was incorporated in 2000 and is based in Newport, Kentucky.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.